CN1333762A - 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 - Google Patents
新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 Download PDFInfo
- Publication number
- CN1333762A CN1333762A CN99815448A CN99815448A CN1333762A CN 1333762 A CN1333762 A CN 1333762A CN 99815448 A CN99815448 A CN 99815448A CN 99815448 A CN99815448 A CN 99815448A CN 1333762 A CN1333762 A CN 1333762A
- Authority
- CN
- China
- Prior art keywords
- cyanoimino
- thiazolidin
- benzylidene
- carbon number
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
化合物 | 甘油三酸酯降低率(%) | 化合物 | 甘油三酸酯降低率(%) |
实施例1实施例2实施例3实施例4实施例6实施例7实施例8实施例9实施例10实施例11实施例12实施例13实施例14实施例15实施例16实施例17实施例19 | 4767644284604749396259553647543738 | 实施例20实施例21实施例22实施例26实施例28实施例32实施例34实施例37实施例39实施例40实施例43实施例45实施例47实施例49实施例51实施例52 | 54486546364771415742674369396744 |
实施例 | 总胆固醇下降率(%) | 甘油三酸脂下降率(%) |
23791415 | 271618151132 | 571712152461 |
Claims (11)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1999/006352 WO2001036402A1 (fr) | 1998-07-14 | 1999-11-12 | Nouveaux derives de 2-(n-cyano-imino)thiazolidin-4-one |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1333762A true CN1333762A (zh) | 2002-01-30 |
CN1159305C CN1159305C (zh) | 2004-07-28 |
Family
ID=14237278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998154482A Expired - Fee Related CN1159305C (zh) | 1999-11-12 | 1999-11-12 | 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 |
Country Status (15)
Country | Link |
---|---|
US (1) | US6380229B1 (zh) |
EP (1) | EP1142885B1 (zh) |
JP (1) | JP4285723B2 (zh) |
KR (1) | KR100608416B1 (zh) |
CN (1) | CN1159305C (zh) |
AT (1) | ATE345332T1 (zh) |
AU (1) | AU767923C (zh) |
CA (1) | CA2355243C (zh) |
DE (1) | DE69934027T2 (zh) |
DK (1) | DK1142885T3 (zh) |
ES (1) | ES2276547T3 (zh) |
HK (1) | HK1041691B (zh) |
IL (1) | IL144229A (zh) |
PT (1) | PT1142885E (zh) |
WO (1) | WO2001036402A1 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2383347A1 (en) | 1999-08-31 | 2001-03-08 | Maxia Pharmaceuticals, Inc. | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
JP2001199888A (ja) * | 2000-01-24 | 2001-07-24 | Fujimoto Brothers:Kk | 糖尿病治療剤 |
IL157740A0 (en) | 2001-03-07 | 2004-03-28 | Incyte San Diego Inc | Heterocyclic derivatives and pharmaceutical compositions containing the same |
US7265139B2 (en) | 2001-03-08 | 2007-09-04 | Incyte San Diego Inc. | RXR activating molecules |
JP2004530690A (ja) | 2001-05-16 | 2004-10-07 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症性薬剤として有用なジアリールウレア誘導体 |
AU2002352706A1 (en) | 2001-11-15 | 2003-06-10 | Maxia Pharmaceuticals, Inc. | N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases |
AR037714A1 (es) * | 2001-12-06 | 2004-12-01 | Maxia Pharmaceuticals Inc | Derivados de tiazolidinona y oxazolidinona 2-sustituidos para la inhibicion de fosfatasas y el tratamiento de cancer |
US7102000B2 (en) | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US7196108B2 (en) | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
SI1689726T1 (sl) | 2003-11-21 | 2011-01-31 | Actelion Pharmaceuticals Ltd | Derivati 5-(benz-(z)-iliden)-tiazolidin-4-ona kot imunosupresivna sredstva |
USRE43833E1 (en) | 2003-11-21 | 2012-11-27 | Actelion Pharmaceuticals Ltd. | Thiazolidin-4-one derivatives |
CN101541772B (zh) * | 2006-11-23 | 2013-04-17 | 埃科特莱茵药品有限公司 | 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法 |
US8912340B2 (en) | 2006-11-23 | 2014-12-16 | Actelion Pharmaceuticals Ltd. | Process for the preparation of 2-imino-thiazolidin-4-one derivatives |
CN103450077B (zh) * | 2007-06-08 | 2016-07-06 | 满康德股份有限公司 | IRE-1α抑制剂 |
JP6322630B2 (ja) | 2012-08-17 | 2018-05-09 | アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd | (2Z,5Z)−5−(3−クロロ−4−((R)−2,3−ジヒドロキシプロポキシ)ベンジリデン)−2−(プロピルイミノ)−3−(o−トリル)チアゾリジン−4−オンの製造方法及び前記方法において使用される中間体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07165371A (ja) | 1993-10-06 | 1995-06-27 | Japan Tobacco Inc | テープ巻き付け方法および装置 |
JPH0892249A (ja) * | 1994-07-20 | 1996-04-09 | Sankyo Co Ltd | スルホンアミド誘導体 |
JP3871354B2 (ja) * | 1994-07-29 | 2007-01-24 | 株式会社フジモト・コーポレーション | 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体 |
JPH08157461A (ja) * | 1994-12-07 | 1996-06-18 | Sankyo Co Ltd | スルホン誘導体 |
JPH09165371A (ja) | 1995-10-09 | 1997-06-24 | Sankyo Co Ltd | 複素環化合物を含有する医薬 |
ATE231136T1 (de) * | 1996-04-09 | 2003-02-15 | Reddys Lab Ltd Dr | Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften, verfahren zu deren herstellung und pharmazeutischen zusammenstellungen, die sie enthalten |
JP2000026438A (ja) * | 1998-07-14 | 2000-01-25 | Fujimoto Brothers:Kk | 新規な2−(n−シアノイミノ)チアゾリジン−4− オン誘導体 |
-
1999
- 1999-11-12 ES ES99974189T patent/ES2276547T3/es not_active Expired - Lifetime
- 1999-11-12 KR KR1020017008765A patent/KR100608416B1/ko not_active IP Right Cessation
- 1999-11-12 EP EP99974189A patent/EP1142885B1/en not_active Expired - Lifetime
- 1999-11-12 CA CA002355243A patent/CA2355243C/en not_active Expired - Fee Related
- 1999-11-12 WO PCT/JP1999/006352 patent/WO2001036402A1/ja active IP Right Grant
- 1999-11-12 US US09/889,103 patent/US6380229B1/en not_active Expired - Lifetime
- 1999-11-12 DK DK99974189T patent/DK1142885T3/da active
- 1999-11-12 CN CNB998154482A patent/CN1159305C/zh not_active Expired - Fee Related
- 1999-11-12 AT AT99974189T patent/ATE345332T1/de active
- 1999-11-12 IL IL144229A patent/IL144229A/en not_active IP Right Cessation
- 1999-11-12 JP JP2001538891A patent/JP4285723B2/ja not_active Expired - Fee Related
- 1999-11-12 PT PT99974189T patent/PT1142885E/pt unknown
- 1999-11-12 DE DE69934027T patent/DE69934027T2/de not_active Expired - Lifetime
- 1999-11-12 AU AU11801/00A patent/AU767923C/en not_active Ceased
-
2002
- 2002-04-19 HK HK02102951.1A patent/HK1041691B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2355243A1 (en) | 2001-05-25 |
KR100608416B1 (ko) | 2006-08-02 |
JP4285723B2 (ja) | 2009-06-24 |
HK1041691B (zh) | 2004-12-24 |
ATE345332T1 (de) | 2006-12-15 |
AU1180100A (en) | 2001-05-30 |
EP1142885A1 (en) | 2001-10-10 |
HK1041691A1 (en) | 2002-07-19 |
AU767923C (en) | 2005-03-24 |
DE69934027D1 (de) | 2006-12-28 |
IL144229A0 (en) | 2002-05-23 |
DE69934027T2 (de) | 2007-06-21 |
WO2001036402A1 (fr) | 2001-05-25 |
EP1142885A4 (en) | 2003-01-29 |
EP1142885B1 (en) | 2006-11-15 |
IL144229A (en) | 2006-10-05 |
ES2276547T3 (es) | 2007-06-16 |
DK1142885T3 (da) | 2007-02-26 |
PT1142885E (pt) | 2007-02-28 |
KR20010108089A (ko) | 2001-12-07 |
AU767923B2 (en) | 2003-11-27 |
CN1159305C (zh) | 2004-07-28 |
CA2355243C (en) | 2009-01-27 |
US6380229B1 (en) | 2002-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1159305C (zh) | 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物 | |
CN1040323C (zh) | 噻唑烷衍生物 | |
DE69916881T2 (de) | Antihypertriglyceridemische, antihyperglykemische, antiangiogene und wundheilende substituierte indolalkansäure | |
US20040209891A1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
CN1040324C (zh) | 新的噻唑烷二酮及含有这些化合物的药剂 | |
Kees et al. | Studies on new acidic azoles as glucose-lowering agents in obese, diabetic db/db mice | |
CA2521621A1 (en) | Compounds for the treatment of metabolic disorders | |
US6555702B2 (en) | Protein kinase inhibitor | |
JP4697973B2 (ja) | 代謝障害の処置のための化合物 | |
CA2522738A1 (en) | Compounds for the treatment of metabolic disorders | |
CN1041760A (zh) | 咪唑啉衍生物及其制备方法 | |
JPH11512095A (ja) | アルドース還元酵素阻害薬および抗高血糖症薬としてのフェノキシ酢酸 | |
JPS6261960A (ja) | 不可逆性ド−パミン−β−ヒドロキシラ−ゼ抑制剤 | |
FR2537140A1 (fr) | Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant | |
EP1857442A3 (en) | Novel antimycobacterial compounds | |
CN1162152C (zh) | 糖尿病治疗剂 | |
US4728739A (en) | Hypoglycemic thiazolidinediones | |
JPH0629271B2 (ja) | ベンゾチアジン―1,1―ジオキシド誘導体及びそれを含有する医薬組成物 | |
DE69629931T2 (de) | 1-(hetero)aryl-4-(kondensiertes thiazol-2-ylalkyl)-piperazin derivate, deren herstellung und deren verwendung in der behandlung von 5-ht1a-rezeptor vermittelten krankheiten | |
JP2009051731A (ja) | 新規アスコクロリン誘導体化合物及びそれを含有する医薬組成物 | |
EP0785924A1 (fr) | Bis-2-aminopyridines, leur procede de preparation et leurs applications contre les parasitoses | |
US5236941A (en) | 5-(2-hydroxy-1-arylethylidene)- and 5-(2-oxo-1-arylethylidene)-2,4-thiazolidinediones and derivatives thereof | |
Land et al. | Derivatives of sulfathiazole | |
JP4393203B2 (ja) | ビグアニド誘導体及びそれを含有する糖尿病治療剤 | |
JPH07309852A (ja) | 新規チアゾリジンジオン化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1041691 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: FUJIMOTO CO., LTD. Free format text: FORMER OWNER: FUJIMOTO PHARMACEUTICAL CO., LTD. Effective date: 20101028 Owner name: FUJIMOTO PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: TOMOYISHI MOTOPULAZEZ CORP. Effective date: 20101028 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20101028 Address after: Osaka Japan Patentee after: FUJIMOTO Co.,Ltd. Address before: Osaka Japan Patentee before: FUJIMOTO PHARMACEUTICAL Corp. Effective date of registration: 20101028 Address after: Osaka Japan Patentee after: FUJIMOTO PHARMACEUTICAL Corp. Address before: Osaka Japan Patentee before: Fujimoto Brothers Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040728 Termination date: 20141112 |
|
EXPY | Termination of patent right or utility model |